Replies to post #13993 on Sorrento Therapeutics Inc (SRNE)

[1776club]

Don't know what you don't know. Thought his former buy was a signal.
Barnum said a sucker is born every minute and today a sucker is born every second. Calls,at $0.26 are easy to divest of over a year and a half. Stock is a real money outlay; I'll give him that.
No discussions of buyout or partnership in the works or the good doctor could not make this play per SEC regulations.
He needs money, $200 million/quarter, so pretty smart move. I see nothing in 2022. I don't see a lot of hay in the barn for the horses to pull this over the finish line.
By the way, Bio Vintage. Inc, in case you don't know...
Henry H. Ji is an entrepreneur and businessperson who founded Sorrento Therapeutics, Inc., Sorrento Therapeutics, Inc., BioVintage, Inc. and Stratagene Genomics, Inc. and who has been at the helm of 6 different companies.

He occupies the position of Chairman, President & Chief Executive Officer at Sorrento Therapeutics, Inc., Chairman at SCILEX Pharmaceuticals, Inc., Executive Chairman of Scilex Holding Co. and Chief Executive Officer & Chief Financial Officer at Scintilla Pharmaceuticals, Inc. (which are all subsidiaries of Sorrento Therapeutics, Inc.) and President for BioVintage, Inc.